Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

Pérez-Nadales, E. ; Alastruey-Izquierdo, A. ; Linares-Sicilia, M.J. ; Soto-Debrán, J.C. ; Abdala, E. ; García-Rodríguez, J. ; Montejo, M. ; Muñoz, P. ; Lletí, M.S. ; Rezusta, A. (Universidad de Zaragoza) ; de Pipaón, M.R.P. ; Yáñez, L. ; Merino, E. ; Campos-Herrero, M.I. ; Costa-Mateo, J.M. ; Fortún, J. ; García-Lozano, T. ; Garcia-Vidal, C. ; Fernández-Ruiz, M. ; Sánchez-Reus, F. ; Castro-Méndez, C. ; Guerrero-Lozano, I. ; Soler-Palacín, P. ; Aguado, J.M. ; Martínez-Martínez, L. ; Torre-Cisneros, J. ; Nucci, M.

Resumen: In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 339.

Idioma: Inglés

DOI: 10.3201/eid2701.190782

Año: 2021

Publicado en: Emerging Infectious Diseases 27, 1 (2021), 26-35
ISSN: 1080-6040

Factor impacto JCR: 16.126 (2021)

Categ. JCR: INFECTIOUS DISEASES rank: 9 / 96 = 0.094 (2021) - Q1 - T1
Categ. JCR: IMMUNOLOGY rank: 13 / 163 = 0.08 (2021) - Q1 - T1

Factor impacto CITESCORE: 13.0 - Medicine (Q1)

Factor impacto SCIMAGO: 3.67 - Infectious Diseases (Q1) - Epidemiology (Q1)

Financiación: info:eu-repo/grantAgreement/EUR/ERDF/A way to achieve Europe
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CP18-00073
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-REIPI/RD16-CIII-0004-0003
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-REIPI/RD16-0016-0008

Tipo y forma: Article (Published version)

Área (Departamento): Área Microbiología (Dpto. Microb.Ped.Radio.Sal.Pú.)